This site is intended for Healthcare professionals only.

Piramal Enterprises announces sale of BST-CarGel

Piramal Enterprises announces sale of BST-CarGel

MUMBAI: Piramal Enterprises announced sale of BST-CarGel from Piramal Healthcare (Canada) Ltd to Smith & Nephew, a global medical technology business.

Through this transaction, an affiliate of Smith & Nephew plc will acquire ownership of all product and intellectual property assets related to BST-CarGel, a company statement said here.

The company, however, did not disclose the value of transaction

BST-CarGel is a first-line cartilage repair product used along with microfracture and other bone marrow stimulation techniques for the initial treatment of most sizes of focal cartilage tears.

The transaction does not have a material impact on the financials of PEL, the release said.

0 comment(s) on Piramal Enterprises announces sale of BST-CarGel

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted
    Source: PTI

    Featured Jobs

    View all medical jobs at ➤

    Opinion Polls

    Should Government Doctors be allowed to do Private Practice?